News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
GREGORY JULIA P
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/04/2023 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Nurix Therapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $9.44, valued at
$236k
|
|
05/04/2023 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Ltd.
Txns:
| Granted 52,906 options to buy
@ $13.2, valued at
$698.4k
|
|
10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/22/2021 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Sold 12,000 shares
@ $125, valued at
$1.5M
Exercised 12,000 options to buy
@ $23.63, valued at
$283.6k
|
|
05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/01/2020 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Granted 18,000 options to buy
@ $47.1, valued at
$847.8k
|
|
11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/23/2019 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Granted 18,000 options to buy
@ $61.76, valued at
$1.1M
|
|
02/25/2019 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Sold 12,000 shares
@ $43.56, valued at
$522.7k
Exercised 12,000 options to buy
@ $23.63, valued at
$283.6k
|
|
05/03/2018 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Granted 18,000 options to buy
@ $28.76, valued at
$517.7k
|
|
|
|